Literature DB >> 61488

Intravenous prostaglandin E1 in severe peripheral vascular disease.

L A Carlson, A G Olsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 61488     DOI： 10.1016/s0140-6736(76)90653-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Treatment of postherpetic neuralgia with prostaglandin E1 ointment a preliminary study.

Authors:  J Shirakawa; Y Kimura; Y Horikawa; H Obara
Journal:  J Anesth       Date:  1992-01       Impact factor: 2.078

2.  Can drug therapy alter the natural course of peripheral vascular disease?: a review.

Authors:  C A Clyne
Journal:  Proc R Soc Med       Date:  1977

3.  Prostaglandin E1 therapy for digital ulcers in scleroderma.

Authors:  M Baron; G Skrinskas; M B Urowitz; P N Madras
Journal:  Can Med Assoc J       Date:  1982-01-01       Impact factor: 8.262

4.  Prostaglandin therapy in severe limb ischemia.

Authors:  B J Pardy; H H Eastcott
Journal:  World J Surg       Date:  1983-05       Impact factor: 3.352

5.  Treatment of severe Raynaud's phenomenon with prostaglandin E1.

Authors:  J A Allen; M J O'Reilly
Journal:  Ir J Med Sci       Date:  1981-06       Impact factor: 1.568

6.  Effects of prostaglandin E1 and other vasodilator agents in pulmonary hypertension of scleroderma.

Authors:  M Baron; G Skrinskas; R Hyland; M B Urowitz
Journal:  Br Heart J       Date:  1982-09

7.  Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.

Authors:  M F Martin; P M Dowd; E F Ring; E D Cooke; P A Dieppe; J D Kirby
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

8.  Effect of prostaglandin E1 on deposition of autologous labelled platelets onto human atherosclerotic lesions in vivo.

Authors:  H Sinzinger; J O'Grady; P Fitscha
Journal:  Postgrad Med J       Date:  1987-04       Impact factor: 2.401

9.  Accelerated blood clearance phenomenon upon repeated injection of PEG-modified PLA-nanoparticles.

Authors:  Tsutomu Ishihara; Miho Takeda; Haruka Sakamoto; Ayumi Kimoto; Chisa Kobayashi; Naoko Takasaki; Kanae Yuki; Ken-ichiro Tanaka; Mitsuko Takenaga; Rie Igarashi; Taishi Maeda; Naoki Yamakawa; Yoshinari Okamoto; Masami Otsuka; Tatsuhiro Ishida; Hiroshi Kiwada; Yutaka Mizushima; Tohru Mizushima
Journal:  Pharm Res       Date:  2009-07-25       Impact factor: 4.200

10.  Initial impressions of dazoxiben in the treatment of the ischaemic limb.

Authors:  A T Raftery; S Livesey; J Forty
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.